We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Chemours' (CC) Opteon XL41 Selected by Johnson Controls
Read MoreHide Full Article
The Chemours Company (CC - Free Report) has been chosen by Johnson Controls International plc to provide Opteon XL41 (R-454B) refrigerant for its residential and commercial HVAC products, as well as its air-cooled scroll chiller applications.
Chemours’ Opteon XL41 is a non-ozone depleting refrigerant that reduces the global warming potential (GWP), which is energy-efficient and lowers charge size when compared to the R-410A refrigerant. It enables a reduction in carbon emission in manufacturing and is a smart option ensuring the optimal balance of long-term performance, safety and viability in future air conditioners.
In this regard, Johnson Controls’ decision bears testimony to its commitment to addressing climate change and also sustainability goals to phase out the use of high GWP refrigerants, riding on the back of a similar decision made by the HVAC industry.
Chemours is keen on assisting Johnson Controls in meeting its client needs by providing the avant-garde, low-GWP refrigerant solution. The company is dedicated to partnering with the broader HVACR community with technologies that allow them to function sustainably and minimize environmental impact by bringing down the use of hydrofluorocarbons (HFC) in the United States. It is also renowned for commercializing and driving the adoption of next-generation refrigerants in the HVAC industry and providing low GWP refrigerant solutions.
Johnson Controls noted that among several low-GWP alternatives, Opteon XL41 was evaluated to be the best-in-class option with regard to key metrics of safety, capacity, efficiency, reliability, availability and longevity. Hopefully, this decision will be a step toward helping its customers achieve a 16% reduction in emission by 2030.
Shares of Chemours have surged 164.8% in a year compared with the industry’s rise of 59.4%. The estimated earnings growth rate for the company for the current year is pegged at 51.5%.
Image Source: Zacks Investment Research
Chemours’ top line increased around 10% year over year to $1,436 million in the first quarter, beating the Zacks Consensus Estimate of $1,383.4 million. Adjusted earnings of 71 cents per share also surpassed the Zacks Consensus Estimate of 68 cents.
Chemours expects adjusted EBITDA between $1-$1.15 billion for 2021. It also now sees adjusted earnings per share between $2.84 and $3.56 for the year, up from the prior view of $2.40-$3.12. The company also expects a free cash flow of more than $450 million for the year.
Orion has a projected earnings growth rate of 61.5% for the current year. The company’s shares have grown 83.7% in a year.
Tronox has a projected earnings growth rate of 242.9% for the current year. The company’s shares have seen a surge of 235% in a year.
Univar has a projected earnings growth rate of 35.2% for the current year. The company’s shares have jumped 71.1% in a year.
Time to Invest in Legal Marijuana
If you’re looking for big gains, there couldn’t be a better time to get in on a young industry primed to skyrocket from $17.7 billion back in 2019 to an expected $73.6 billion by 2027.
After a clean sweep of 6 election referendums in 5 states, pot is now legal in 36 states plus D.C. Federal legalization is expected soon and that could be a still greater bonanza for investors. Even before the latest wave of legalization, Zacks Investment Research has recommended pot stocks that have shot up as high as +285.9%.
You’re invited to check out Zacks’ Marijuana Moneymakers: An Investor’s Guide. It features a timely Watch List of pot stocks and ETFs with exceptional growth potential.
Image: Bigstock
Chemours' (CC) Opteon XL41 Selected by Johnson Controls
The Chemours Company (CC - Free Report) has been chosen by Johnson Controls International plc to provide Opteon XL41 (R-454B) refrigerant for its residential and commercial HVAC products, as well as its air-cooled scroll chiller applications.
Chemours’ Opteon XL41 is a non-ozone depleting refrigerant that reduces the global warming potential (GWP), which is energy-efficient and lowers charge size when compared to the R-410A refrigerant. It enables a reduction in carbon emission in manufacturing and is a smart option ensuring the optimal balance of long-term performance, safety and viability in future air conditioners.
In this regard, Johnson Controls’ decision bears testimony to its commitment to addressing climate change and also sustainability goals to phase out the use of high GWP refrigerants, riding on the back of a similar decision made by the HVAC industry.
Chemours is keen on assisting Johnson Controls in meeting its client needs by providing the avant-garde, low-GWP refrigerant solution. The company is dedicated to partnering with the broader HVACR community with technologies that allow them to function sustainably and minimize environmental impact by bringing down the use of hydrofluorocarbons (HFC) in the United States. It is also renowned for commercializing and driving the adoption of next-generation refrigerants in the HVAC industry and providing low GWP refrigerant solutions.
Johnson Controls noted that among several low-GWP alternatives, Opteon XL41 was evaluated to be the best-in-class option with regard to key metrics of safety, capacity, efficiency, reliability, availability and longevity. Hopefully, this decision will be a step toward helping its customers achieve a 16% reduction in emission by 2030.
Shares of Chemours have surged 164.8% in a year compared with the industry’s rise of 59.4%. The estimated earnings growth rate for the company for the current year is pegged at 51.5%.
Chemours’ top line increased around 10% year over year to $1,436 million in the first quarter, beating the Zacks Consensus Estimate of $1,383.4 million. Adjusted earnings of 71 cents per share also surpassed the Zacks Consensus Estimate of 68 cents.
Chemours expects adjusted EBITDA between $1-$1.15 billion for 2021. It also now sees adjusted earnings per share between $2.84 and $3.56 for the year, up from the prior view of $2.40-$3.12. The company also expects a free cash flow of more than $450 million for the year.
The Chemours Company Price and Consensus
The Chemours Company price-consensus-chart | The Chemours Company Quote
Zacks Rank & Other Stocks to Consider
Currently, Chemours carries a Zacks Rank #2 (Buy).
Some other top-ranked stocks in the basic materials space are Orion Engineered Carbons S.A (OEC - Free Report) , Tronox Holdings PLC (TROX - Free Report) and Univar Solutions Inc. , each sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Orion has a projected earnings growth rate of 61.5% for the current year. The company’s shares have grown 83.7% in a year.
Tronox has a projected earnings growth rate of 242.9% for the current year. The company’s shares have seen a surge of 235% in a year.
Univar has a projected earnings growth rate of 35.2% for the current year. The company’s shares have jumped 71.1% in a year.
Time to Invest in Legal Marijuana
If you’re looking for big gains, there couldn’t be a better time to get in on a young industry primed to skyrocket from $17.7 billion back in 2019 to an expected $73.6 billion by 2027.
After a clean sweep of 6 election referendums in 5 states, pot is now legal in 36 states plus D.C. Federal legalization is expected soon and that could be a still greater bonanza for investors. Even before the latest wave of legalization, Zacks Investment Research has recommended pot stocks that have shot up as high as +285.9%.
You’re invited to check out Zacks’ Marijuana Moneymakers: An Investor’s Guide. It features a timely Watch List of pot stocks and ETFs with exceptional growth potential.
Today, Download Marijuana Moneymakers FREE >>